Similar Papers

Paper Title
Journal
Date
Author
Abstract A51: Quantitative assessment of VEGF combined with known clinical variables predicts outcome in patients with diffuse large B-cell lymphoma (DLBCL): Implications for guiding future treatment selection.
Michael J Donovan ... Pere Puig
Molecular Cancer Therapeutics | VOL. 10
Michael J Donovan, et. al.Michael J Donovan ... Pere Puig
12 Nov 2011
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer
Rami S Vanguri ... Eileen P Connolly
Clinical Breast Cancer | VOL. 22
Rami S Vanguri, et. al.Rami S Vanguri ... Eileen P Connolly
18 Apr 2022
Usefulness of the Addition of Beta-2-Microglobulin, Cystatin C and C-Reactive Protein to an Established Risk Factors Model to Improve Mortality Risk Prediction in Patients Undergoing Coronary Angiography
Kevin T Nead ... Nicholas J Leeper
The American Journal of Cardiology | VOL. 111
Kevin T Nead, et. al.Kevin T Nead ... Nicholas J Leeper
01 Jan 2013
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.
Michael Cecchini ... Jeffrey Sklar
Cancer research communications | VOL. 3
Michael Cecchini, et. al.Michael Cecchini ... Jeffrey Sklar
28 Jun 2023
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Aniek E.M Schouten ... Anne M May
Journal of Clinical Oncology | VOL. -
Aniek E.M Schouten, et. al.Aniek E.M Schouten ... Anne M May
13 Jan 2025
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
Jennifer L Crombie ... Ann S Lacasce
Journal of Clinical Oncology | VOL. -
Jennifer L Crombie, et. al.Jennifer L Crombie ... Ann S Lacasce
07 Jan 2025
Should Total Neoadjuvant Therapy Be the First-Line Treatment for Patients With Locally Advanced Rectal Cancer?
Mahsoem Ali ... Geert Kazemier
Journal of Clinical Oncology | VOL. -
Mahsoem Ali, et. al.Mahsoem Ali ... Geert Kazemier
06 Jan 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study
Jacob Sands ... Luis Paz-Ares
Journal of Clinical Oncology | VOL. -
Jacob Sands, et. al.Jacob Sands ... Luis Paz-Ares
06 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.